A new study suggests limiting your eating window could be a simpler and more sustainable way to lose weight than tracking ...

Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...

Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood ...

Tirzepatide is the active ingredient in an injectable medication (Zepbound) approved by the U.S. Food and Drug Administration (FDA) to treat obesity and overweight in adults with other weight-related ...

As more people turn to ChatGPT for diet advice, therapists warn AI could complicate eating disorder recovery by offering ...

After Anurag Kashyap's 27 kg weight loss, doctors warn that crash diets after a heart attack can jeopardize recovery and ...

Doctors say repeated diet failure may reflect underlying medical conditions or metabolic changes, with newer obesity ...

A once-daily Wegovy weight loss pill is now available to buy privately from UK high street and online pharmacies. The tablet contains semaglutide, the same active ingredient used in Wegovy injections, ...

This eating plan is considered a fad diet. Fad diets often promote quick weight loss that is unsustainable and may severely restrict what you eat. They may be harmful and generally do not have ...

The Korean Switch-On Diet is a fad diet that incorporates multiple eating strategies. Learn why dietitians don’t recommend it ...

Semaglutide is the active ingredient in several U.S. Food and Drug Administration (FDA)-approved treatment options for ...

GLP-1 weight-loss drugs will cost $50 a month for many older adults starting July 1, as Medicare begins to cover them. How the Medicare GLP-1 Bridge plan works.